// App-Quantinova.ai

2199 : TLR3-induced immune response using PLGA nanoparticles for dendritic cell-based cancer immunotherapy

Researchers

Presenter

  • HEEDONG HAN

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • HLA class I histocompatibility antigen B-57

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved